Drugs for Treating Mental Disorders Market - Global Outlook and Forecast 2021-2027

April 2021 | 108 pages | ID: DFBF7EEF85FEEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Drugs for Treating Mental Disorders in Global, including the following market information:

Global Drugs for Treating Mental Disorders Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Drugs for Treating Mental Disorders market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Treating Mental Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drugs for Treating Mental Disorders Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Drugs for Treating Mental Disorders Market Segment Percentages, By Type, 2020 (%)

• Tablets
• Capsule
• Injection
• Solution
• Other

China Drugs for Treating Mental Disorders Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Drugs for Treating Mental Disorders Market Segment Percentages, By Application, 2020 (%)

• Antipsychotics
• Antidepressants
• Antianxiety (Anxiolyitcs)
• Anti-Seizure Medications
• Stimulants
• Cognitive Disorders And Dementia
• Sleep Disorder Treatments
• Substance Abuse Treatments
• Hypnosis And Tranquilizers
• Other

Global Drugs for Treating Mental Disorders Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Drugs for Treating Mental Disorders Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Drugs for Treating Mental Disorders Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Drugs for Treating Mental Disorders Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Johnson and Johnson
• Pfizer
• Eli Lilly
• GlaxoSmithKline
• AstraZeneca
• Bristol-Myers Squibb
• Teva Pharmaceutical
• Dr. Reddy's Laboratories
• Apotex Inc.
• Mylan Pharmaceuticals
• Par Pharmaceutical
• Aurobindo Pharma
• Torrent Pharmaceuticals
• Jubilant Lifesciences
• Sun Pharmaceutical
• Sandoz (Novartis)
• Hansoh Pharmaceutical
• WATSON Pharmaceuticals
• Zhejiang Langhua Pharmaceuticals
• Forest Laboratories
• H.Lundbeck A/S
• Amneal Pharmaceuticals
• Hetero Drugs
• Macleods Pharmaceuticals
• Silarx Pharmacueticals
• Hikma Pharmaceuticals
• Lupin Limited
• Prinston Pharmaceutical
• STI Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drugs for Treating Mental Disorders Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Drugs for Treating Mental Disorders Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRUGS FOR TREATING MENTAL DISORDERS OVERALL MARKET SIZE

2.1 Global Drugs for Treating Mental Disorders Market Size: 2021 VS 2027
2.2 Global Drugs for Treating Mental Disorders Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Drugs for Treating Mental Disorders Players in Global Market
3.2 Top Global Drugs for Treating Mental Disorders Companies Ranked by Revenue
3.3 Global Drugs for Treating Mental Disorders Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Treating Mental Disorders Companies in Global Market, by Revenue in 2020
3.5 Global Companies Drugs for Treating Mental Disorders Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Treating Mental Disorders Players in Global Market
  3.6.1 List of Global Tier 1 Drugs for Treating Mental Disorders Companies
  3.6.2 List of Global Tier 2 and Tier 3 Drugs for Treating Mental Disorders Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Drugs for Treating Mental Disorders Market Size Markets, 2021 & 2027
  4.1.2 Tablets
  4.1.3 Capsule
  4.1.4 Injection
  4.1.5 Solution
  4.1.6 Other
4.2 By Type - Global Drugs for Treating Mental Disorders Revenue & Forecasts
  4.2.1 By Type - Global Drugs for Treating Mental Disorders Revenue, 2016-2021
  4.2.2 By Type - Global Drugs for Treating Mental Disorders Revenue, 2022-2027
  4.2.3 By Type - Global Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Drugs for Treating Mental Disorders Market Size, 2021 & 2027
  5.1.2 Antipsychotics
  5.1.3 Antidepressants
  5.1.4 Antianxiety (Anxiolyitcs)
  5.1.5 Anti-Seizure Medications
  5.1.6 Stimulants
  5.1.7 Cognitive Disorders And Dementia
  5.1.8 Sleep Disorder Treatments
  5.1.9 Substance Abuse Treatments
  5.1.10 Hypnosis And Tranquilizers
  5.1.11 Other
5.2 By Application - Global Drugs for Treating Mental Disorders Revenue & Forecasts
  5.2.1 By Application - Global Drugs for Treating Mental Disorders Revenue, 2016-2021
  5.2.2 By Application - Global Drugs for Treating Mental Disorders Revenue, 2022-2027
  5.2.3 By Application - Global Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Drugs for Treating Mental Disorders Market Size, 2021 & 2027
6.2 By Region - Global Drugs for Treating Mental Disorders Revenue & Forecasts
  6.2.1 By Region - Global Drugs for Treating Mental Disorders Revenue, 2016-2021
  6.2.2 By Region - Global Drugs for Treating Mental Disorders Revenue, 2022-2027
  6.2.3 By Region - Global Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Drugs for Treating Mental Disorders Revenue, 2016-2027
  6.3.2 US Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.3.3 Canada Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.3.4 Mexico Drugs for Treating Mental Disorders Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Drugs for Treating Mental Disorders Revenue, 2016-2027
  6.4.2 Germany Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.4.3 France Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.4.4 U.K. Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.4.5 Italy Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.4.6 Russia Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.4.7 Nordic Countries Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.4.8 Benelux Drugs for Treating Mental Disorders Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Drugs for Treating Mental Disorders Revenue, 2016-2027
  6.5.2 China Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.5.3 Japan Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.5.4 South Korea Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.5.5 Southeast Asia Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.5.6 India Drugs for Treating Mental Disorders Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Drugs for Treating Mental Disorders Revenue, 2016-2027
  6.6.2 Brazil Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.6.3 Argentina Drugs for Treating Mental Disorders Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Drugs for Treating Mental Disorders Revenue, 2016-2027
  6.7.2 Turkey Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.7.3 Israel Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.7.4 Saudi Arabia Drugs for Treating Mental Disorders Market Size, 2016-2027
  6.7.5 UAE Drugs for Treating Mental Disorders Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Johnson and Johnson
  7.1.1 Johnson and Johnson Corporate Summary
  7.1.2 Johnson and Johnson Business Overview
  7.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Major Product Offerings
  7.1.4 Johnson and Johnson Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.1.5 Johnson and Johnson Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Drugs for Treating Mental Disorders Major Product Offerings
  7.2.4 Pfizer Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.2.5 Pfizer Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Drugs for Treating Mental Disorders Major Product Offerings
  7.3.4 Eli Lilly Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.3.5 Eli Lilly Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Major Product Offerings
  7.4.4 GlaxoSmithKline Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.4.5 GlaxoSmithKline Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca Drugs for Treating Mental Disorders Major Product Offerings
  7.5.4 AstraZeneca Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.5.5 AstraZeneca Key News
7.6 Bristol-Myers Squibb
  7.6.1 Bristol-Myers Squibb Corporate Summary
  7.6.2 Bristol-Myers Squibb Business Overview
  7.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Major Product Offerings
  7.6.4 Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.6.5 Bristol-Myers Squibb Key News
7.7 Teva Pharmaceutical
  7.7.1 Teva Pharmaceutical Corporate Summary
  7.7.2 Teva Pharmaceutical Business Overview
  7.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
  7.4.4 Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.7.5 Teva Pharmaceutical Key News
7.8 Dr. Reddy's Laboratories
  7.8.1 Dr. Reddy's Laboratories Corporate Summary
  7.8.2 Dr. Reddy's Laboratories Business Overview
  7.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Major Product Offerings
  7.8.4 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.8.5 Dr. Reddy's Laboratories Key News
7.9 Apotex Inc.
  7.9.1 Apotex Inc. Corporate Summary
  7.9.2 Apotex Inc. Business Overview
  7.9.3 Apotex Inc. Drugs for Treating Mental Disorders Major Product Offerings
  7.9.4 Apotex Inc. Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.9.5 Apotex Inc. Key News
7.10 Mylan Pharmaceuticals
  7.10.1 Mylan Pharmaceuticals Corporate Summary
  7.10.2 Mylan Pharmaceuticals Business Overview
  7.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
  7.10.4 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.10.5 Mylan Pharmaceuticals Key News
7.11 Par Pharmaceutical
  7.11.1 Par Pharmaceutical Corporate Summary
  7.11.2 Par Pharmaceutical Business Overview
  7.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
  7.11.4 Par Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.11.5 Par Pharmaceutical Key News
7.12 Aurobindo Pharma
  7.12.1 Aurobindo Pharma Corporate Summary
  7.12.2 Aurobindo Pharma Business Overview
  7.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Major Product Offerings
  7.12.4 Aurobindo Pharma Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.12.5 Aurobindo Pharma Key News
7.13 Torrent Pharmaceuticals
  7.13.1 Torrent Pharmaceuticals Corporate Summary
  7.13.2 Torrent Pharmaceuticals Business Overview
  7.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
  7.13.4 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.13.5 Torrent Pharmaceuticals Key News
7.14 Jubilant Lifesciences
  7.14.1 Jubilant Lifesciences Corporate Summary
  7.14.2 Jubilant Lifesciences Business Overview
  7.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Major Product Offerings
  7.14.4 Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.14.5 Jubilant Lifesciences Key News
7.15 Sun Pharmaceutical
  7.15.1 Sun Pharmaceutical Corporate Summary
  7.15.2 Sun Pharmaceutical Business Overview
  7.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
  7.15.4 Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.15.5 Sun Pharmaceutical Key News
7.16 Sandoz (Novartis)
  7.16.1 Sandoz (Novartis) Corporate Summary
  7.16.2 Sandoz (Novartis) Business Overview
  7.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Major Product Offerings
  7.16.4 Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.16.5 Sandoz (Novartis) Key News
7.17 Hansoh Pharmaceutical
  7.17.1 Hansoh Pharmaceutical Corporate Summary
  7.17.2 Hansoh Pharmaceutical Business Overview
  7.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
  7.17.4 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.17.5 Hansoh Pharmaceutical Key News
7.18 WATSON Pharmaceuticals
  7.18.1 WATSON Pharmaceuticals Corporate Summary
  7.18.2 WATSON Pharmaceuticals Business Overview
  7.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
  7.18.4 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.18.5 WATSON Pharmaceuticals Key News
7.19 Zhejiang Langhua Pharmaceuticals
  7.19.1 Zhejiang Langhua Pharmaceuticals Corporate Summary
  7.19.2 Zhejiang Langhua Pharmaceuticals Business Overview
  7.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
  7.19.4 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.19.5 Zhejiang Langhua Pharmaceuticals Key News
7.20 Forest Laboratories
  7.20.1 Forest Laboratories Corporate Summary
  7.20.2 Forest Laboratories Business Overview
  7.20.3 Forest Laboratories Drugs for Treating Mental Disorders Major Product Offerings
  7.20.4 Forest Laboratories Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.20.5 Forest Laboratories Key News
7.21 H.Lundbeck A/S
  7.21.1 H.Lundbeck A/S Corporate Summary
  7.21.2 H.Lundbeck A/S Business Overview
  7.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Major Product Offerings
  7.21.4 H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.21.5 H.Lundbeck A/S Key News
7.22 Amneal Pharmaceuticals
  7.22.1 Amneal Pharmaceuticals Corporate Summary
  7.22.2 Amneal Pharmaceuticals Business Overview
  7.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
  7.22.4 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.22.5 Amneal Pharmaceuticals Key News
7.23 Hetero Drugs
  7.23.1 Hetero Drugs Corporate Summary
  7.23.2 Hetero Drugs Business Overview
  7.23.3 Hetero Drugs Drugs for Treating Mental Disorders Major Product Offerings
  7.23.4 Hetero Drugs Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.23.5 Hetero Drugs Key News
7.24 Macleods Pharmaceuticals
  7.24.1 Macleods Pharmaceuticals Corporate Summary
  7.24.2 Macleods Pharmaceuticals Business Overview
  7.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
  7.24.4 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.24.5 Macleods Pharmaceuticals Key News
7.25 Silarx Pharmacueticals
  7.25.1 Silarx Pharmacueticals Corporate Summary
  7.25.2 Silarx Pharmacueticals Business Overview
  7.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Major Product Offerings
  7.25.4 Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.25.5 Silarx Pharmacueticals Key News
7.26 Hikma Pharmaceuticals
  7.26.1 Hikma Pharmaceuticals Corporate Summary
  7.26.2 Hikma Pharmaceuticals Business Overview
  7.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
  7.26.4 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.26.5 Hikma Pharmaceuticals Key News
7.27 Lupin Limited
  7.27.1 Lupin Limited Corporate Summary
  7.27.2 Lupin Limited Business Overview
  7.27.3 Lupin Limited Drugs for Treating Mental Disorders Major Product Offerings
  7.27.4 Lupin Limited Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.27.5 Lupin Limited Key News
7.28 Prinston Pharmaceutical
  7.28.1 Prinston Pharmaceutical Corporate Summary
  7.28.2 Prinston Pharmaceutical Business Overview
  7.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
  7.28.4 Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.28.5 Prinston Pharmaceutical Key News
7.29 STI Pharma
  7.29.1 STI Pharma Corporate Summary
  7.29.2 STI Pharma Business Overview
  7.29.3 STI Pharma Drugs for Treating Mental Disorders Major Product Offerings
  7.29.4 STI Pharma Drugs for Treating Mental Disorders Revenue in Global (2016-2021)
  7.29.5 STI Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Drugs for Treating Mental Disorders Market Opportunities & Trends in Global Market
Table 2. Drugs for Treating Mental Disorders Market Drivers in Global Market
Table 3. Drugs for Treating Mental Disorders Market Restraints in Global Market
Table 4. Key Players of Drugs for Treating Mental Disorders in Global Market
Table 5. Top Drugs for Treating Mental Disorders Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Drugs for Treating Mental Disorders Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Drugs for Treating Mental Disorders Revenue Share by Companies, 2016-2021
Table 8. Global Companies Drugs for Treating Mental Disorders Product Type
Table 9. List of Global Tier 1 Drugs for Treating Mental Disorders Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Treating Mental Disorders Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Drugs for Treating Mental Disorders Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Drugs for Treating Mental Disorders Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Drugs for Treating Mental Disorders Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Drugs for Treating Mental Disorders Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Drugs for Treating Mental Disorders Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Drugs for Treating Mental Disorders Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2022-2027
Table 30. Johnson and Johnson Corporate Summary
Table 31. Johnson and Johnson Drugs for Treating Mental Disorders Product Offerings
Table 32. Johnson and Johnson Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Drugs for Treating Mental Disorders Product Offerings
Table 35. Pfizer Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Drugs for Treating Mental Disorders Product Offerings
Table 38. Eli Lilly Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Drugs for Treating Mental Disorders Product Offerings
Table 41. GlaxoSmithKline Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Drugs for Treating Mental Disorders Product Offerings
Table 44. AstraZeneca Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 45. Bristol-Myers Squibb Corporate Summary
Table 46. Bristol-Myers Squibb Drugs for Treating Mental Disorders Product Offerings
Table 47. Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 48. Teva Pharmaceutical Corporate Summary
Table 49. Teva Pharmaceutical Drugs for Treating Mental Disorders Product Offerings
Table 50. Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 51. Dr. Reddy's Laboratories Corporate Summary
Table 52. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product Offerings
Table 53. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 54. Apotex Inc. Corporate Summary
Table 55. Apotex Inc. Drugs for Treating Mental Disorders Product Offerings
Table 56. Apotex Inc. Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 57. Mylan Pharmaceuticals Corporate Summary
Table 58. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 59. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 60. Par Pharmaceutical Corporate Summary
Table 61. Par Pharmaceutical Drugs for Treating Mental Disorders Product Offerings
Table 62. Par Pharmaceutical Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 63. Aurobindo Pharma Corporate Summary
Table 64. Aurobindo Pharma Drugs for Treating Mental Disorders Product Offerings
Table 65. Aurobindo Pharma Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 66. Torrent Pharmaceuticals Corporate Summary
Table 67. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 68. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 69. Jubilant Lifesciences Corporate Summary
Table 70. Jubilant Lifesciences Drugs for Treating Mental Disorders Product Offerings
Table 71. Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 72. Sun Pharmaceutical Corporate Summary
Table 73. Sun Pharmaceutical Drugs for Treating Mental Disorders Product Offerings
Table 74. Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 75. Sandoz (Novartis) Corporate Summary
Table 76. Sandoz (Novartis) Drugs for Treating Mental Disorders Product Offerings
Table 77. Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 78. Hansoh Pharmaceutical Corporate Summary
Table 79. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product Offerings
Table 80. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 81. WATSON Pharmaceuticals Corporate Summary
Table 82. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 83. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 84. Zhejiang Langhua Pharmaceuticals Corporate Summary
Table 85. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 86. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 87. Forest Laboratories Corporate Summary
Table 88. Forest Laboratories Drugs for Treating Mental Disorders Product Offerings
Table 89. Forest Laboratories Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 90. H.Lundbeck A/S Corporate Summary
Table 91. H.Lundbeck A/S Drugs for Treating Mental Disorders Product Offerings
Table 92. H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 93. Amneal Pharmaceuticals Corporate Summary
Table 94. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 95. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 96. Hetero Drugs Corporate Summary
Table 97. Hetero Drugs Drugs for Treating Mental Disorders Product Offerings
Table 98. Hetero Drugs Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 99. Macleods Pharmaceuticals Corporate Summary
Table 100. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 101. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 102. Silarx Pharmacueticals Corporate Summary
Table 103. Silarx Pharmacueticals Drugs for Treating Mental Disorders Product Offerings
Table 104. Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 105. Hikma Pharmaceuticals Corporate Summary
Table 106. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 107. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 108. Lupin Limited Corporate Summary
Table 109. Lupin Limited Drugs for Treating Mental Disorders Product Offerings
Table 110. Lupin Limited Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 111. Prinston Pharmaceutical Corporate Summary
Table 112. Prinston Pharmaceutical Drugs for Treating Mental Disorders Product Offerings
Table 113. Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)
Table 114. STI Pharma Corporate Summary
Table 115. STI Pharma Drugs for Treating Mental Disorders Product Offerings
Table 116. STI Pharma Drugs for Treating Mental Disorders Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Drugs for Treating Mental Disorders Segment by Type
Figure 2. Drugs for Treating Mental Disorders Segment by Application
Figure 3. Global Drugs for Treating Mental Disorders Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Drugs for Treating Mental Disorders Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Drugs for Treating Mental Disorders Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Treating Mental Disorders Revenue in 2020
Figure 8. By Type - Global Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027
Figure 9. By Application - Global Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027
Figure 10. By Region - Global Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027
Figure 11. By Country - North America Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027
Figure 12. US Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027
Figure 16. Germany Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 17. France Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027
Figure 24. China Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 28. India Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027
Figure 30. Brazil Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Drugs for Treating Mental Disorders Revenue Market Share, 2016-2027
Figure 33. Turkey Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2016-2027
Figure 37. Johnson and Johnson Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Eli Lilly Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. GlaxoSmithKline Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. AstraZeneca Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Apotex Inc. Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Par Pharmaceutical Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Aurobindo Pharma Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Forest Laboratories Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 59. Hetero Drugs Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 60. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 61. Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 62. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 63. Lupin Limited Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 64. Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2016-2021)